🌅 Pre-Market Briefing — 2026-06-24 · 10:37 PDT

Apple had no company-specific catalyst; coverage focused on Alphabet's addition to the Dow alongside megacap tech.

AbbVie had no material catalyst; items included a Botox Cosmetic marketing program and a generic dividend-growth article.

Alamos Gold slipped after two seismic events at Young-Davidson (one at an active mining front) led BMO to cut its price target to C$73 and expect reduced 2026 mining rates.

UBS raised its AMD price target to $670 (from $455), citing demand from standalone CPU racks for agentic AI workloads.

Micron was trading ahead of its Q3 earnings report due after the close, with options pricing a large swing.

Nvidia had no specific catalyst; coverage centered on Alphabet joining the Dow and broader market/dollar moves.

Palantir had no company-specific catalyst; it featured only in chip-stock rebound roundups.

Supermicro announced a collaboration with StorMagic for high-availability edge infrastructure; coverage also flagged rising inventory and weak operating cash flow.

Sunrun unveiled a virtual power plant partnership with Tesla and Renew Home to aggregate 16+ GW of distributed capacity from home batteries and smart devices for utilities and AI data centers.

MiniMed launched its Instinct continuous glucose sensors in Europe, expanding sensor choice for diabetes patients.

SiteOne Landscape Supply is hosting its 2026 Investor Day in Atlanta; the retrieved article was about an unrelated company (RenoWorks).

FIGS announced participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference.

Benchmark Electronics is the manufacturing partner for Ouster's Rev8 color digital lidar under a high-volume supply deal with AIM, and was separately named HPE's Manufacturing Partner of the Year.

Definium's late-stage trial of an LSD formulation significantly outperformed placebo in major depression (analysts called it a best-case result), and the company priced a $700M upsized public offering.

KB Home reported Q2 results with stronger gross margins but soft homebuyer demand and order growth, and discussed a built-to-order reset.

Telix signed a non-binding MoU with United Imaging Healthcare for a US theranostics research collaboration, initially around its Pixclara PET imaging candidate.

ICON's move followed its 2026 outlook, a share buyback and a governance shake-up, against the backdrop of an Audit Committee revenue-recognition investigation it expects to restate by under 2% per year.

The State of Maryland decided to acquire the Preakness IP rights from Churchill Downs.

Enerflex published its 2026 Investor Update presentation; coverage otherwise was generic Zacks momentum/ranking pieces.

Janus Living announced the dates of its Q2 2026 earnings release, conference call and webcast; it recently IPO'd, with parent Healthpeak retaining ~81.6%.

Robert Half had no company-specific news; staffing stocks rose after peer Korn/Ferry beat earnings and revenue estimates.

A footwear sector roundup cited continued acceleration for Amer Sports' Arc'teryx and Salomon brands amid a broader DTC slowdown.

BofA upgraded Brown-Forman, saying it enters fiscal 2027 with well-supported guidance.

Spyre fell after a Form 4 showed Fairmount Healthcare Fund II, affiliated with a board member, sold ~$399.7M of common stock and exited its common position, even as the company touted positive SPY002 induction data.

Hub Group disclosed its interim CFO will receive $125K monthly, with Q4 results pending.

Cerebras fell after its full-year margin forecast disappointed investors, even as its AI-chip demand outlook improved.

Grupo Aeromexico announced a webcast date for its Q2 2026 results, with no other company-specific catalyst.

Houlihan Lokey expanded its GP-led secondaries capabilities into real estate via a senior hire in its Capital Solutions Group.

AngloGold Ashanti fell with gold miners amid easing geopolitical risk; coverage was a generic brokerage-rating piece.

Sibanye-Stillwater had no fresh catalyst; recent items were a senior-notes tender/refinancing and a Pd-103 nuclear-medicine JV with Necsa.

A Bloomberg report said Ghana's government is weighing shifting control of Tarkwa — Gold Fields' largest mine — to local businesses after current leases expire in April 2027; Gold Fields says it filed an early renewal application and is in talks.

Harmony Gold fell with the gold-mining sector; the only company item was a Zacks upgrade to Buy on improving earnings estimates.

A definitive technology-licensing agreement was signed with Topsoe and Sasol for a Cerilon gas-to-liquids facility in North Dakota; the item is small relative to Sasol's scale.

Churchill Capital Corp XI announced a ~$2.5B SPAC merger to take Nvidia-backed humanoid-robot maker Agility Robotics public on the Nasdaq.

Wendy's surged ~30% on a Reddit/WallStreetBets retail rally citing a new CFO hire, store closures, China plans and speculation about a Trian/Nelson Peltz buyout.

Absci reported positive interim Phase 1 safety data for ABS-201, an anti-prolactin-receptor antibody for androgenetic alopecia, with no serious adverse events across single ascending doses.

FuelCell Energy signed a supply agreement with Fit Energy for up to 380MW of on-site fuel-cell power for data centers, receiving an immediate deposit on an initial 30MW with deliveries starting later this year.

InMode confirmed an unsolicited $16.20/share all-cash proposal (a ~21% premium, ~$1.03B) from MN Business Strategy, a group including co-founder/CEO Moshe Mizrahy, and formed a special committee to evaluate it.